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BaCKgrOUND: Down Syndrome (DS) is one of the most frequent genetic abnormalities and the related otolaryngologic disorders may affect 
a full potential development and the quality of life of these patients. the aim of the present study was to evaluate which treatment, medical or 
surgical, may improve otolaryngologic symptoms.
MEtHODS: We conducted a case-control study considering the number of acute pharyngo-tonsillitis febrile episodes (PtFE), presence of ob-
structive sleep apnea (OSa) and middle ear disease in patients with DS referred to our centers. We selected 34 subjects with more severe symp-
toms and clinical course subdivided in two groups, the first group constituted by patients that underwent conservative therapy and the second 
group by those who underwent surgical therapy.
RESULTS: After surgical treatment we found a significant (P<0.01) reduction of PTFE and OSA grade with a normalization of tympanometry 
(P<0.01). Conversely, we observed a reduction of symptoms only in few cases (P>0.05) that underwent medical therapy. No major complications 
related to DS were observed in surgical therapy.
CONClUSiONS: adenotonsillectomy appears to be more helpful than medical therapy in DS subjects determining OSa, balanced with surgical 
risks/benefits, respiratory and ear function improvement.
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Down Syndrome (DS) is the commonest genetic ab-normality and affects approximately 1:660 to 1:800 
children born.1 in the last years advances in surgical treat-
ments of congenital heart defects have greatly enhanced 
the survival of DS, but the increasing life expectancy has 
revealed the presence of unexpected pathological pro-
cesses.2
it is widely accepted that DS children suffer from more 
frequent infections than normal children, and most stud-
ies agree that these affect mainly the respiratory tract.3 
Patients with DS have several morphologic abnormali-
ties (mid-face hypoplasia, Eustachian tube dysfunction, 
abnormalities of the oropharynx and rhinopharynx, and 
shortened palate) that predispose them to ear, nose, and 
throat (ENt) problems. Common ENt manifestations in 
DS children include ear infections and hearing loss, ob-
structive sleep apnea (OSa) subglottic stenosis, chronic 
rhinorrhea and sinusitis, as well as important anesthetic 
considerations.4
approximately one-third of children with DS have re-
current otitis media with effusion (OME) that requires 
close monitoring.5 Etiologic factors include an increased 
incidence of upper respiratory tract infections (Urti), 
possibly due to the immaturity of the immune system. in 
addition, the mid-face hypoplasia, the shape of Eustachian 
tube, more cylindrical and smaller in width, and the hy-
potonia of the tensor veli palatini muscle predispose to 
chronic ear disease.4
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all the mentioned ENt disorders can affect the poten-
tial development and quality of life of these patients. Con-
sequently, appropriate treatments may be required to man-
age the disease causing ENt manifestations. For instance, 
hearing loss can affect a child’s educational, language, 
and social development and then it must be diagnosed and 
treated aggressively.
Furthermore, the prevalence of OSa is greater among 
children with DS or other chronic pediatric or psychiatric 
conditions, than among children in general. good-quality 
sleep is important for learning, attention and memory pro-
cesses.6 On the other hand, sleep disruption may exacer-
bate learning difficulties and disturbed behavior that are 
the consequence of the developmental disorder itself.7 OSa 
could be related also to sensorineural hearing impairment.8
the adenotonsillectomy could be one of more reli-
able surgical solution to ENt symptoms (i.e., otitis due 
to Eustachian tube obstruction, OSa due to tonsil hyper-
trophy); even if is a documented treatment for OSa in 
non-syndromic children9 there is actually divergence in 
literature supporting adenotonsillectomy for OSa in DS 
children.10-13
the aim of the present case-control study was to evalu-
ate the efficacy of adenotonsillectomy in children with DS.
Materials and methods
a case-control study of DS patients observed and/or treat-
ed in our institutions was done. the patient personal data 
were collected and recorded.
Table I.— Parameters evaluated in the first clinical examination.
Evaluated parameters
Number of pharyngo-tonsillar febrile episodes
Increase in body temperature ≥38 °C with catarrhal or follicular angina 
with reference to the past 12 months. We considered three classes 
according to the frequency of febrile episodes:
• Class 0: no or 1 febrile episode per year;
• Class i: 2-4 episodes per year;
• Class II: 5 or more episodes per year
Tonsillar hypertrophy
Clinical evaluation of the degree of tonsillar hypertrophy performed 
according to the Mallampati criteria: Grade 0: tonsils within tonsillar 
fossa; Grade 1+: tonsils <25% of space between pillar; Grade 2+: 
tonsils <50% of space between pillars; Grade 3+: tonsils <75% of space 
between pillars; Grade 4+: tonsils >75% of space between pillars
Endoscopic evaluation of the nose and rhinopharynx
Performed with the patient in a sitting and lying position with a 2.7-mm 
flexible endoscope by the same investigator. No decongestant was used.
Nasal status was scored as follows: (0) normal turbinates/no discharge; 
(1) clear and thin discharge; (2) thick and purulent discharge; absence 
(0) and presence (1) of edema.
adenoid hypertrophy was scored: (1) choanal openings free or adenoid 
tissue confined to the upper segment in the rhinopharynx (<25%); (2) 
adenoid tissue occupying only the upper segment in the rhinopharynx 
(≥25% to <50%); (3) adenoid tissue extended over the half volume of 
rhinopharynx (≥50% to <75%), (4) total choanal obstruction (>75% to 
100%)
Overnight polysomnography (PSG) (Apnoescreen II plus)
record of the respiratory distress index (rDi), the apnea-hypopnea index 
(aHi) and the mean oxygen saturation (SaO2%) during sleep. OSA was 
defined absent (RDI 1-3, SaO2 97-100%), mild (RDI 3-5, SaO2 96%), 
moderate (RDI 5-10, SaO2 95%) and severe (RDI>10, SaO2 94%)
Middle ear involvement
Diagnosed on the basis of otoscopy (tympanic atelectasis), tympanometry 
(shape of curve type A, B, C) and acoustic reflectometry, to verify the 
presence of middle ear disease
Table II.— Characteristics of Down Syndrome patients.
age (years) N. Obstructive sleep apnea Middle ear 
disease
Pharyngotonsillar febrile episode
absent Mild Moderate Severe Class 0 Class i Class ii
0-1 30 2 (6.6%) 5 (27%) 8 (27%) 15 (50%) 22 (73.3%) 20 (66.6%) 6 (20%) 4 (13%)
1-2 29 5 (17%) 5 (17%) 5 (17%) 14 (48%) 20 (68.9%) 8 (27.5%) 13 (44.8%) 8 (27.5%)
2-3 18 3 (17%) 1 (5.5%) 9 (50%) 5 (28%) 13 (72.2%) 5 (27.5%) 8 (44.4%) 5 (27.7%)
3-4 19 5 (26%) 3 (5.2%) 7 (36%) 6 (31%) 10 (52.6%) 4 (21%) 7 (36.8%) 8 (42.1%)
4-5 25 9 (36%) 5 (10%) 6 (24%) 5 (20%) 12 (48%) 10 (20%) 10 (40%) 5 (20%)
5-6 27 7 (26%) 7 (26%) 8 (30%) 5 (18%) 12 (44.4%) 8 (29.6%) 13 (48.1%) 6 (22.2%)
total 148 31 (21%) 24 (16%) 43 (29%) 50 (34%) 89 55 (37.2%) 57 (38.5%) 36 (24.3%)
Table III.— Selected patients (N.=34) characteristics before and after surgical and medical treatment.
type of treatment
Before At 18 months
PtFE Class i PtFE Class ii Moderate OSa Severe OSa MEi PtFE Class i PtFE Class ii Moderate OSa Severe OSa MEi
Surgical treatment 9/17 (52.9%) 8 /17 (47%) 10/17 (58.8%) 7/17 (41.1%) 17/17 (100%) 2/17 (11.7%) 0/17 3/17 (17.6%) 0/17 2/17 (11.7%)
Medical treatment 9/17 (52.9%) 8/17 (47%) 10/17 (58.8%) 7/17 (41.1%) 17/17 (100%) 8/17 (47%) 6/17 (35.3%) 10/17 (58.8%) 5/17 (29.4%) 14/17 (82.3%)
PtFE: pharyngotonsillar febrile episode; OSa: obstructive sleep apnea; MEi: middle ear involvement.
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nasal endoscopy, otoscopy, tympanometry and acoustic re-
flectometry. A PSG was repeater after 12 months.
Statistical analysis
Distributions of continuous variables in different groups 
were analyzed by Student’s t-test parametric method. For 
categorical variables the comparisons were performed by 
using the χ2 test in MS Excel.
Results
A total of 148 DS patients were observed in our Institutions 
among 2004-2010. Mean age was 3.4 years. The 54.7% of 
patients was male. Clinical characteristics of patients are 
reported in table ii.
After the first clinical consultation we selected 34 pa-
tients matching our criteria with more severe ENt in-
volvement; mean age 5,1 years old (range 3-6) for surgical 
subgroup and 5.3 years old (range 3-6) for medical sub-
group (P>0.05).
After 18 months of follow-up in the subgroup of pa-
tients who underwent adenotonsillectomy there was a sta-
tistically significant reduction of number of PTFE class I 
and II (from 17/17 to 2/17 patients, P<0.01), of moderate 
and severe OSA (from 17/17 to 3/17 patients, P<0.01) and 
of pathological tympanograms from (from 17/17 to 2/17 
patients, P<0.01).
No complications occurred after adenotonsillectomy.
Conversely, in the subgroup of patients who underwent 
medical therapy there was no statistically significant re-
duction of number of PTFE (from 17/17 patients to 14/17, 
P>0.05), of moderate and severe OSA (from 17/17 patients 
to 15/17, P>0.05) and of pathological tympanograms 
(from 17/17 patients to 14/17, P>0.05).
Overall statistical significance showed a P<0.01 be-
tween surgical and medical treatment.
all results are summarized in table iii and iV.
Discussion
Health advances in medical care on the one hand have 
lengthened the life expectancy for children with DS, on 
the institutional Ethics Committee approved the study 
protocol. all parents gave written informed consent for 
their children’s participation in the clinical pathway and in 
the study. all subjects were accompanied during the study 
by one or both parents.
During the first clinical consultation patients were eval-
uated for: number of pharyngo-tonsillar febrile episodes 
(PtFE) referred to the past 12 months, tonsillar hypertro-
phy grading, endoscopic evaluation of the nose and rhino-
pharynx with grading of obstruction, overnight polysom-
nography (PSg), and middle ear involvement (otoscopy, 
tympanometry, stapedial reflex). Parameters definitions 
are reported in table i.
a group of patients with severe ENt manifestations, 
matching the inclusion criteria, was addressed for treat-
ment.
Severe ENT involvement was defined by the simulta-
neously presence of: number of pharyngo-tonsillar febrile 
episodes (PtFE) class i and ii; tonsillar hypertrophy 3 to 
4; adenoid hypertrophy grade 3 to 4; PSg: OSa moder-
ate to severe; bilateral pathological tympanograms as flat 
(type B) or peak compliance below zero (type C).
Exclusion criteria: age under 2 years, severe contraindi-
cation to surgery due to cardiac malformations, pulmonary 
issue.
We subdivided the group of patients with more severe 
ENt involvement into two subgroups by a blocked ran-
domization (size of block 4 patients). The first subgroup 
includes those underwent cold adenoidectomy and cold 
dissection tonsillectomy with bipolar coagulation when 
needed. the surgery was performed in rose position un-
der general anesthesia with oral-tracheal intubation. all 
patients were hospitalized overnight after surgery. the 
complications occurred were recorded. the second sub-
group included those underwent medical therapy with 
beclomethasone 200 µg twice a day and N-acetylcysteine 
200 mg/twice/day by aerosol for two weeks; amoxicillin 
with clavulanate 25 mg/kg twice per day were adminis-
tered only in case of recurrence of tonsillar symptoms or 
exacerbation of nasal infections.
Both groups were followed-up with a clinical control 
every 3 months for 18 months with objective examination, 
Table III.— Selected patients (N.=34) characteristics before and after surgical and medical treatment.
type of treatment
Before At 18 months
PtFE Class i PtFE Class ii Moderate OSa Severe OSa MEi PtFE Class i PtFE Class ii Moderate OSa Severe OSa MEi
Surgical treatment 9/17 (52.9%) 8 /17 (47%) 10/17 (58.8%) 7/17 (41.1%) 17/17 (100%) 2/17 (11.7%) 0/17 3/17 (17.6%) 0/17 2/17 (11.7%)
Medical treatment 9/17 (52.9%) 8/17 (47%) 10/17 (58.8%) 7/17 (41.1%) 17/17 (100%) 8/17 (47%) 6/17 (35.3%) 10/17 (58.8%) 5/17 (29.4%) 14/17 (82.3%)
PtFE: pharyngotonsillar febrile episode; OSa: obstructive sleep apnea; MEi: middle ear involvement.
P
R
O
O
F
M
IN
ER
VA
 M
ED
IC
A
PROFF ID.indd   1 10/09/10   14:28
DiSPENZa  aDENOtONSillECtOMY iN DOWN SYNDrOME
4 OtOriNOlariNgOlOgia Mese 2019 
fectiveness, the surgical treatment may expose the DS pa-
tients to anesthetic complications such as bradycardia, air-
way issue, difficult intubation, and post-intubation croup.4 
For these reasons it is important that the anesthesiologist 
has a good understanding of the pathophysiology of DS 
children. thus overnight hospitalization after surgery and 
special vigilance in the postoperative period should be 
needed.5 No complications linked to surgical procedures, 
or general anesthesia, were recorded in our series.
DS subjects are predisposed to a higher functional re-
spiratory vulnerability and 70% of children with DS show 
residual or recurrent OSa after surgery. On account of this, 
we recommend a careful clinical and instrumental follow-
up extended also after following years.
Conclusions
the adenotonsillectomy appears to be more helpful than 
medical therapy in DS subjects with OSa, improving 
significantly PTFE, respiratory and middle ear function. 
Because of high risk of anesthetic and postoperative com-
plications the candidates for surgery should be only chil-
dren with high frequency and severity of febrile episodes, 
pathological tympanometry as well as children with high 
degree of adenotonsillar hypertrophy with a moderate to 
severe OSA influencing their quality of life and psycho-
logical condition.
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